Recent Posts
- AndzonBio1 raises initial €3M in seed funding to advance breakthrough treatments for Cardiovascular, Renal and Metabolic Disorders
- Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis focused Pipeline
- ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type 1 (DM1)
- Inserm Transfert and AdBio Partners launch AndzonBio®
- AdBio Partners promotes Emma Gasol to Partner